Real-world analysis of subsequent-line strategies for EGFR C797S mutant non-small cell lung cancer patients acquired resistance to third-generation EGFR tyrosine kinase inhibitors.
- DOI
- 10.1186/s12885-025-15335-x
- Published
- 2025 Dec 22
- Container
- BMC cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-025-15335-x,
title = {Real-world analysis of subsequent-line strategies for EGFR C797S mutant non-small cell lung cancer patients acquired resistance to third-generation EGFR tyrosine kinase inhibitors.},
author = {Xu J and Zhu A and Xu Y and Zhang Y and Shen Y and Niu Y and Zhong H and Zhong R},
year = {2025},
journal = {BMC cancer},
doi = {10.1186/s12885-025-15335-x},
url = {https://doi.org/10.1186/s12885-025-15335-x}
}RIS
TY - JOUR TI - Real-world analysis of subsequent-line strategies for EGFR C797S mutant non-small cell lung cancer patients acquired resistance to third-generation EGFR tyrosine kinase inhibitors. AU - Xu J AU - Zhu A AU - Xu Y AU - Zhang Y AU - Shen Y AU - Niu Y AU - Zhong H AU - Zhong R PY - 2025 JO - BMC cancer DO - 10.1186/s12885-025-15335-x UR - https://doi.org/10.1186/s12885-025-15335-x ER -
APA
J, X., A, Z., Y, X., Y, Z., Y, S., Y, N., H, Z., & R, Z. (2025). Real-world analysis of subsequent-line strategies for EGFR C797S mutant non-small cell lung cancer patients acquired resistance to third-generation EGFR tyrosine kinase inhibitors.. BMC cancer. https://doi.org/10.1186/s12885-025-15335-x
Source records
- pubmed · retrieved 2026-11-10T15:12:40.604Z
- europe-pmc · retrieved 2026-11-10T15:12:40.626Z
- doaj · retrieved 2026-11-10T15:12:40.619Z